ISpecimen Correlations
| ISPC Stock | USD 0.35 0.02 6.06% |
The current 90-days correlation between iSpecimen and ENDRA Life Sciences is 0.23 (i.e., Modest diversification). The correlation of ISpecimen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
ISpecimen Correlation With Market
Excellent diversification
The correlation between iSpecimen and DJI is -0.58 (i.e., Excellent diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding iSpecimen and DJI in the same portfolio, assuming nothing else is changed.
ISpecimen | Build AI portfolio with ISpecimen Stock |
Moving together with ISpecimen Stock
Moving against ISpecimen Stock
| 0.71 | AA | Alcoa Corp | PairCorr |
| 0.64 | WMT | Walmart Common Stock | PairCorr |
| 0.55 | TLKMF | Telkom Indonesia Tbk | PairCorr |
| 0.47 | XOM | Exxon Mobil Corp | PairCorr |
| 0.46 | MCD | McDonalds | PairCorr |
| 0.43 | DD | Dupont De Nemours Earnings Call Next Week | PairCorr |
| 0.42 | PPERY | Bank Mandiri Persero Earnings Call This Week | PairCorr |
| 0.32 | INTC | Intel | PairCorr |
| 0.32 | DIS | Walt Disney Earnings Call Tomorrow | PairCorr |
| 0.31 | GE | GE Aerospace | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between ISpecimen Stock performing well and ISpecimen Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze ISpecimen's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| NDRA | 5.14 | (0.35) | 0.00 | (0.09) | 0.00 | 12.24 | 38.62 | |||
| TOVX | 5.63 | (0.76) | 0.00 | (0.64) | 0.00 | 8.33 | 34.29 | |||
| VTAK | 4.90 | (0.15) | 0.00 | (0.13) | 0.00 | 13.33 | 35.41 | |||
| HSCS | 4.30 | 0.28 | 0.05 | 0.34 | 5.10 | 11.07 | 26.18 | |||
| GLMD | 4.10 | (0.90) | 0.00 | (0.87) | 0.00 | 8.04 | 21.39 | |||
| BJDX | 3.85 | (0.99) | 0.00 | (0.71) | 0.00 | 8.08 | 31.29 | |||
| BIVI | 3.12 | (0.76) | 0.00 | (0.36) | 0.00 | 6.62 | 19.38 | |||
| BIAF | 3.93 | (1.02) | 0.00 | (2.36) | 0.00 | 6.52 | 19.84 | |||
| SHPH | 6.72 | (0.22) | 0.00 | 0.15 | 0.00 | 15.69 | 44.53 | |||
| ZCMD | 4.60 | (0.40) | 0.00 | (1.70) | 0.00 | 9.30 | 61.79 |
ISpecimen Corporate Management
| Emily Hubbard | VP Devel | Profile | |
| Benjamin Bielak | Chief Secretary | Profile | |
| Eric Langlois | Chief Officer | Profile | |
| Dawn Michelle | VP Operations | Profile | |
| Yuying Liang | Chief Officer | Profile | |
| Annette Arnold | Vice Development | Profile |